Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition (Q63012083)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition |
clinical trial |
Statements
A Single-dose, Two-treatment, Two-sequence, Two-period, Two Way Crossover Bioequivalence Study of Bosiqing Aripiprazole Orally Disintegrating Tablets and ABILIFY Under Fasting/Fed Condition (English)
0 references
26 June 2017
0 references
30 April 2018
0 references
66
0 references
45 year
0 references
65 year
0 references